Doubts Over New Class Of Diabetes Drugs As Roche Gives Up On Aleglitazar
The decision by pharmaceutical giant Roche to cancel all clinical trials of its diabetes drug aleglitazar may dent confidence in
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓